Cargando…
Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies
Chronic obstructive pulmonary disease (COPD) is a major incurable global health burden and is currently the 4th largest cause of death in the world. Importantly, much of the disease burden and health care utilisation in COPD is associated with the management of its comorbidities (e.g. skeletal muscl...
Autores principales: | Chan, Stanley M.H., Selemidis, Stavros, Bozinovski, Steven, Vlahos, Ross |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112632/ https://www.ncbi.nlm.nih.gov/pubmed/30822464 http://dx.doi.org/10.1016/j.pharmthera.2019.02.013 |
Ejemplares similares
-
Chronic obstructive pulmonary disease and atherosclerosis: common mechanisms and novel therapeutics
por: Brassington, Kurt, et al.
Publicado: (2022) -
New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease
por: Brassington, Kurt, et al.
Publicado: (2019) -
Resolving Viral-Induced Secondary Bacterial Infection in COPD: A Concise Review
por: Wang, Hao, et al.
Publicado: (2018) -
Role of Alveolar Macrophages in Chronic Obstructive Pulmonary Disease
por: Vlahos, Ross, et al.
Publicado: (2014) -
Ebselen reduces cigarette smoke‐induced endothelial dysfunction in mice
por: Brassington, Kurt, et al.
Publicado: (2021)